Top Page
Elevate Uranium Ltd
(Sydney:EL8)
Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)
Elevate Uranium Ltd Business Overview & Revenue Model
Elevate Uranium Ltd Financial Statement Overview
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 768.50K | 182.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 768.50K | -121.67K | -117.68K | -85.52K | -54.29K |
| EBITDA | -11.85M | -10.62M | -8.51M | -5.68M | -2.66M |
| Net Income | -12.32M | -10.75M | -8.63M | -5.73M | -2.60M |
Balance Sheet | |||||
| Total Assets | 25.46M | 13.26M | 12.54M | 19.33M | 9.96M |
| Cash, Cash Equivalents and Short-Term Investments | 21.71M | 10.83M | 10.06M | 15.81M | 6.66M |
| Total Debt | 432.41K | 74.21K | 146.03K | 177.27K | 99.29K |
| Total Liabilities | 1.57M | 1.48M | 1.02M | 838.59K | 429.54K |
| Stockholders Equity | 23.89M | 11.78M | 11.52M | 18.49M | 9.53M |
Cash Flow | |||||
| Free Cash Flow | -11.71M | -9.31M | -5.90M | -4.49M | -2.40M |
| Operating Cash Flow | -11.62M | -9.24M | -5.83M | -4.38M | -2.33M |
| Investing Cash Flow | -714.24K | -73.79K | -74.52K | -137.62K | -61.28K |
| Financing Cash Flow | 23.22M | 10.09M | 158.86K | 13.67M | 7.99M |
Elevate Uranium Ltd Technical Analysis
Elevate Uranium Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
54 Neutral | AU$316.35M | -8.30 | -7.01% | ― | -100.00% | 49.49% | |
50 Neutral | AU$172.41M | -10.34 | -69.11% | ― | ― | 1.38% | |
46 Neutral | AU$236.54M | -43.44 | -6.30% | ― | ― | -67.12% | |
46 Neutral | AU$19.92M | -38.00 | -0.93% | ― | ― | 8.33% | |
43 Neutral | AU$147.82M | -8.19 | -26.26% | ― | ― | -75.25% | |
40 Underperform | AU$7.90M | -3.79 | -75.69% | ― | ― | -141.67% |
Elevate Uranium Ltd Corporate Events
Elevate Uranium has outlined a global resource base of 153 million pounds of U3O8 across two top‑tier jurisdictions, positioning itself as an emerging mid‑tier player in the uranium sector. The company reports four discoveries in four years, including 96 million pounds of U3O8 linked to its proprietary U‑grade process, which could improve recoveries and costs as it moves projects from discovery toward development.
A further 57 million pounds of U3O8 is associated with multiple high‑grade prospects, offering diversification and exposure to targets above 1,000 ppm U3O8 that may support higher‑margin production. This growing resource inventory and exploration pipeline underpin Elevate Uranium’s strategy to build critical mass in a strengthening uranium market, potentially enhancing its appeal to investors seeking leveraged exposure to nuclear fuel demand.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.34 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium has delivered a major upgrade to the Mineral Resource Estimate at its Marenica Uranium Project in Namibia, doubling the resource grade to 185 ppm U3O8 for 40.2 million pounds of contained uranium at a 100 ppm cut-off grade, and increasing the resource to 59 million pounds at 124 ppm U3O8 at a 50 ppm cut-off. The update, based on re-analysis of data from more than 5,000 historical drill holes and conversion of the resource to JORC 2012 standards, excludes some mineralised areas due to wide-spaced drilling, with infill programs set to begin this month to reintroduce those zones and upgrade parts of the resource from Inferred to Indicated, materially enhancing Marenica’s development potential and providing a more robust, lower-risk platform for Elevate’s growth ambitions in uranium.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has confirmed the expiry of 14,904,798 listed options (ASX code EL8AT), which were due to expire on 30 January 2026 with an exercise price of A$0.60 and lapsed without being exercised. The cessation of these options reduces the company’s pool of potential future equity dilution but also removes a possible source of additional capital, clarifying the company’s current issued capital structure for existing shareholders and the market.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has confirmed that 14,904,798 unlisted Class EL8AT options, each exercisable at $0.60, expired on 30 January 2026. The lapse of these options marginally simplifies the company’s capital structure by removing a tranche of potential equity dilution from its balance of outstanding securities.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.48 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Limited has disclosed changes in the securities held by Managing Director Murray Hill and his related entities, including his spouse and their self-managed superannuation fund. The notice details a net acquisition of 1,349,486 fully paid ordinary shares in Elevate Uranium at a price of A$0.245 per share through the Carmu Super Fund account, offset by disposals from Hill personally and his spouse. While the transaction does not alter control of the company, it marginally increases Hill’s indirect equity exposure, which may be interpreted by investors as a vote of confidence in Elevate Uranium’s prospects and align the director’s financial interests more closely with those of shareholders.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.38 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has issued 8,923,738 fully paid ordinary shares as part of the consideration to acquire Uranium Generation Pty Ltd from Core Lithium Ltd, linked to the Napperby uranium resource and associated high-grade exploration projects. The company has lodged a cleansing notice confirming that these shares were issued without a prospectus under the Corporations Act and that, by providing this notice, subsequent on-sale of the securities can occur under the relevant disclosure exemption, while also affirming its ongoing compliance with reporting and continuous disclosure obligations and indicating no undisclosed information material to investors’ assessment of the company or the new shares.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has applied for quotation on the ASX of 8,923,738 fully paid ordinary shares, issued on 22 December 2025. The move increases the number of tradeable securities on market under the EL8 code and reflects ongoing capital activity that may support the company’s future funding requirements and liquidity for existing and new shareholders.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Core Lithium has completed the sale of its non-core uranium assets in the Northern Territory and South Australia to Elevate Uranium for a total consideration of A$5 million in cash and shares, plus a 1% net smelter royalty over any future production from the Napperby project tenement. The divestment, which delivers immediate working capital, is intended to sharpen Core’s strategic focus on restarting its flagship Finniss Lithium Project while retaining some exposure to potential future upside from the uranium portfolio via the royalty and equity stake in Elevate.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has completed the acquisition of Uranium Generation Pty Ltd from Core Lithium, adding the Napperby uranium resource in the Northern Territory and the high-grade Fitton and Entia exploration projects in South Australia and the Northern Territory to its portfolio. The deal lifts Elevate’s global mineral resource inventory to 169 million pounds of U3O8 and consolidates a Central Australian hub, with Napperby’s JORC-compliant 8.03-million-pound resource located just 25 km from the company’s Minerva project and considered amenable to its U-pgrade™ process, offering potential value uplift and resource growth through underexplored tenements in supportive Australian uranium jurisdictions.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has requested and been granted a trading halt on its securities on the ASX as it finalises a material acquisition, with the halt effective from 19 December 2025. Trading in the company’s shares is expected to resume by 23 December 2025 or upon the release of further details on the acquisition, a move that signals a potentially significant expansion or strategic shift in Elevate Uranium’s operations and may have important implications for investors once the transaction is disclosed.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced a change in the director’s interest, specifically regarding Murray Hill’s holdings. The change involved the disposal of 1,900,000 unlisted options by Murray Philip Hill & Carol Ann Hill’s Carmu Super Fund A/C, with no new acquisitions reported. This adjustment in holdings could influence the company’s stock dynamics and investor perceptions, reflecting internal strategic decisions.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced the cessation of 4,200,000 securities, specifically options that expired on December 16, 2025, without being exercised or converted. This cessation of securities may affect the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced that 4,200,000 of its unlisted options, exercisable at $0.61 each, expired on December 16, 2025. This expiration may impact the company’s financial strategy and investor relations, as it involves a significant number of options that were not exercised, potentially affecting future capital-raising activities.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has successfully assembled and is nearing the completion of commissioning its proprietary U-pgrade™ Demonstration/Pilot Plant in Namibia. This development marks a significant milestone for the company, as it prepares to commence steady state operations in January 2026. The plant aims to validate the U-pgrade™ beneficiation process on a continuous operational basis, using ore from the Koppies and Marenica projects. The data collected will inform technical studies for these projects, potentially enhancing the company’s industry positioning and operational capabilities.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced the issuance of new unquoted equity securities, including options and rights, as part of a previously disclosed transaction. This issuance involves 2,865,711 unquoted options exercisable at $0.41, expiring in 2029, and a total of 1,305,699 rights with varying expiration dates. This move is part of the company’s strategic financial maneuvers to support its operations and growth, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced a change in the director’s interest, with Scott Perry acquiring 695,837 service options exercisable at $0.41 per option, expiring on December 1, 2029. This acquisition, following shareholder approval, reflects a strategic move to align the director’s interests with the company’s growth objectives, potentially impacting its market positioning positively.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd has announced the grant of unlisted securities following shareholder approval. These include service options and performance rights issued to the company’s directors and managing director, Murray Hill. The securities are structured to vest over several years, aligning with the company’s long-term strategic goals and performance indicators. This move is likely to strengthen the company’s leadership incentives and align their interests with shareholder value, potentially impacting its operational focus and market positioning.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.29 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.
Elevate Uranium Ltd announced the successful passing of all resolutions at its Annual General Meeting held on 27 November 2025. The resolutions included the adoption of the remuneration report, re-election of director Scott Perry, issuance of service options to key personnel, and approval of a 10% placement capacity. These decisions are likely to enhance the company’s governance and operational capacity, potentially impacting its strategic positioning in the uranium market.
The most recent analyst rating on (AU:EL8) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Elevate Uranium Ltd stock, see the AU:EL8 Stock Forecast page.